Related Experiment Video
Updated: Aug 12, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Therapy of penicillin-resistant pneumococcal meningitis
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology
|January 1, 1995
Summary
Antimicrobial therapy for pneumococcal meningitis must adapt to rising penicillin resistance in Streptococcus pneumoniae. Current guidelines recommend third-generation cephalosporins or vancomycin based on susceptibility testing and vaccination strategies.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Pneumococcal meningitis treatment is evolving due to increasing penicillin resistance in Streptococcus pneumoniae.
- Emergence of strains with elevated minimal inhibitory concentrations (MICs) necessitates revised therapeutic approaches.
Discussion:
- For regions with relatively penicillin-resistant strains (MICs 0.1-1.0 µg/ml), empiric therapy with cefotaxime or ceftriaxone is advised.
- Highly penicillin-resistant strains (MICs ≥2 µg/ml) warrant vancomycin, potentially combined with rifampin.
- Cerebrospinal fluid (CSF) isolate susceptibility testing is crucial for guiding antimicrobial selection.
Key Insights:
- Penicillin G resistance patterns in Streptococcus pneumoniae are shifting, impacting meningitis treatment.
- Third-generation cephalosporins and vancomycin are key alternatives for resistant pneumococcal meningitis.
- Empiric therapy choices depend on local resistance prevalence and susceptibility data.
Outlook:
- Continued surveillance of pneumococcal susceptibility is essential for refining treatment guidelines.
- Strict adherence to vaccination recommendations for at-risk populations can reduce infection incidence.
- Further research may explore novel therapeutic strategies for multidrug-resistant pneumococcal meningitis.
Related Concept Videos
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...